These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1002 related items for PubMed ID: 23457043
1. MicroRNA-146a targets PRKCE to modulate papillary thyroid tumor development. Zhang X, Li D, Li M, Ye M, Ding L, Cai H, Fu D, Lv Z. Int J Cancer; 2014 Jan 15; 134(2):257-67. PubMed ID: 23457043 [Abstract] [Full Text] [Related]
2. Nuclear factor-{kappa}B contributes to anaplastic thyroid carcinomas through up-regulation of miR-146a. Pacifico F, Crescenzi E, Mellone S, Iannetti A, Porrino N, Liguoro D, Moscato F, Grieco M, Formisano S, Leonardi A. J Clin Endocrinol Metab; 2010 Mar 15; 95(3):1421-30. PubMed ID: 20061417 [Abstract] [Full Text] [Related]
3. MicroRNA miR-146b-5p regulates signal transduction of TGF-β by repressing SMAD4 in thyroid cancer. Geraldo MV, Yamashita AS, Kimura ET. Oncogene; 2012 Apr 12; 31(15):1910-22. PubMed ID: 21874046 [Abstract] [Full Text] [Related]
4. MiR-34a targets GAS1 to promote cell proliferation and inhibit apoptosis in papillary thyroid carcinoma via PI3K/Akt/Bad pathway. Ma Y, Qin H, Cui Y. Biochem Biophys Res Commun; 2013 Nov 29; 441(4):958-63. PubMed ID: 24220341 [Abstract] [Full Text] [Related]
5. Thyroid hormone receptor beta (THRB) is a major target gene for microRNAs deregulated in papillary thyroid carcinoma (PTC). Jazdzewski K, Boguslawska J, Jendrzejewski J, Liyanarachchi S, Pachucki J, Wardyn KA, Nauman A, de la Chapelle A. J Clin Endocrinol Metab; 2011 Mar 29; 96(3):E546-53. PubMed ID: 21159845 [Abstract] [Full Text] [Related]
6. Family of microRNA-146 Regulates RARβ in Papillary Thyroid Carcinoma. Czajka AA, Wójcicka A, Kubiak A, Kotlarek M, Bakuła-Zalewska E, Koperski Ł, Wiechno W, Jażdżewski K. PLoS One; 2016 Mar 29; 11(3):e0151968. PubMed ID: 27011326 [Abstract] [Full Text] [Related]
7. MicroRNA-146a modulates B-cell oncogenesis by regulating Egr1. Contreras JR, Palanichamy JK, Tran TM, Fernando TR, Rodriguez-Malave NI, Goswami N, Arboleda VA, Casero D, Rao DS. Oncotarget; 2015 May 10; 6(13):11023-37. PubMed ID: 25906746 [Abstract] [Full Text] [Related]
9. Can the microRNA signature distinguish between thyroid tumors of uncertain malignant potential and other well-differentiated tumors of the thyroid gland? Lassalle S, Hofman V, Ilie M, Bonnetaud C, Puisségur MP, Brest P, Loubatier C, Guevara N, Bordone O, Cardinaud B, Lebrigand K, Rios G, Santini J, Franc B, Mari B, Al Ghuzlan A, Vielh P, Barbry P, Hofman P. Endocr Relat Cancer; 2011 Oct 10; 18(5):579-94. PubMed ID: 21778212 [Abstract] [Full Text] [Related]